Russell Investments Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,898
Closed -$38K 3279
2021
Q2
$38K Sell
2,898
-24,718
-90% -$609K ﹤0.01% 3153
2021
Q1
$1.41M Buy
27,616
+167
+0.6% +$10K ﹤0.01% 2083
2020
Q4
$1.7M Sell
27,449
-634
-2% -$36.3K ﹤0.01% 1846
2020
Q3
$1.54M Sell
28,083
-152
-0.5% -$8.18K ﹤0.01% 1852
2020
Q2
$1.62M Buy
28,235
+14,761
+110% +$803K ﹤0.01% 1764
2020
Q1
$540K Buy
+13,474
New +$572K ﹤0.01% 2141
2019
Q3
Sell
-47,109
Closed -$421K 3122
2019
Q2
$421K Sell
47,109
-35,042
-43% -$406K ﹤0.01% 2315
2019
Q1
$1.1M Buy
82,151
+14,700
+22% +$168K ﹤0.01% 2011
2018
Q4
$738K Buy
67,451
+5,477
+9% +$57.8K ﹤0.01% 2140
2018
Q3
$670K Hold
61,974
﹤0.01% 2269
2018
Q2
$866K Sell
61,974
-3,097
-5% -$37K ﹤0.01% 2189
2018
Q1
$885K Buy
65,071
+23,745
+57% +$245K ﹤0.01% 2253
2017
Q4
$244K Sell
41,326
-36,546
-47% -$251K ﹤0.01% 2620
2017
Q3
$578K Sell
77,872
-38,215
-33% -$318K ﹤0.01% 2388
2017
Q2
$1.09M Buy
116,087
+21,922
+23% +$161K ﹤0.01% 2065
2017
Q1
$686K Buy
94,165
+31,997
+51% +$230K ﹤0.01% 2300
2016
Q4
$483K Buy
+62,168
New +$448K ﹤0.01% 2480

Other funds holding CCXI

Russell Investments Group's CCXI Position: Q3 2021 in Review

Russell Investments Group sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 2,898 shares — an estimated $38K sold.

Russell Investments Group first reported a position in CCXI in Q4 2016 and held it in 17 quarters. The position peaked at $1.7M in Q4 2020. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Russell Investments Group reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Russell Investments Group sold 2,898 ChemoCentryx, Inc. shares in Q3 2021, an estimated $38K.
  • Russell Investments Group first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 17 quarters.
  • Russell Investments Group's ChemoCentryx, Inc. position peaked at $1.7M in Q4 2020.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.